Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-08
2005-02-08
Weddington, Kevin E. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S241000, C514S248000, C514S250000, C514S258100, C514S303000
Reexamination Certificate
active
06852722
ABSTRACT:
The present invention is directed to methods for stimulating the motility of the gastrointestinal system in a patient which comprises administering a growth hormone secretagogue, a prodrug thereof or a pharmaceutically acceptable salt of said secretagogue or said prodrug. More particularly, the present invention provides methods for stimulating the motility of the gastrointestinal system in a patient which comprises administering a compound of Formula I:a prodrug thereof or a pharmaceutically acceptable salt of said secretagogue or said prodrug.
REFERENCES:
patent: 4962115 (1990-10-01), Van Daele
patent: 6251902 (2001-06-01), Carpino et al.
patent: 6376509 (2002-04-01), Bakshi et al.
patent: WO 9724369 (1997-07-01), None
patent: WO 9858947 (1998-12-01), None
patent: WO 9858949 (1998-12-01), None
Smith, et al. “Peptidomimetic Regulation of Growth Hormone Secretion”,Endocrine Reviews18(5), pp. 621-645 (1997).
Ankersen, et al., “Growth hormone secretagogues: recent advances and applications”,DDT4(11), pp. 497-506 (1999).
Casanueva, et al., “Growth Hormone Secretagogues: Physiological Role and Clinical Utility”,TEM10(1), pp. 30-38 (1999).
Shulman, “Gastrointestinal Effects of Growth Hormone”,Endocrine12(2), pp. 147-152 (2000).
Feighner, et al., “Receptor for Motilin Identified in the Human Gastrointestinal System”,Science284, pp. 2184-2188 (1999).
Faghih, et al., “Motilides and motilactides: design and development of motilin receptor agonists as a new class of gastrointestinal prokinetic drugs”,Science23(8), pp. 861-872 (1998).
Kirst, et al., “Recent developments with macrolide antibiotics”,Exp. Opin. Ther. Patents8(2), pp. 111-120 (1998).
Kojima, et al., “Ghrelin is a growth-hormone-releasing acylated peptide from stomach”,Nature402, pp. 656-660 (1999).
Slonim, et al. “A Preliminary Study of Growth Hormone Therapy for Crohn's Disease”,The New England Journal of Medicine342(22), pp. 1633-1637 (2000).
Faghih, et al., “Synthesis of 9-Deoxo-4-deoxy-6,9-epoxyerythromycin Derivatives: Novel and Acid-Stable Motilides”,J. Med. Chem. 41, pp. 3402-3408 (1998).
Masuda, et al., “Ghrelin Stimulates Gastric Acid Secretion and Motility in Rats”,Biochem and Biophys. Res. Comm. 276, pp. 905-908 (2000).
Svensson, et al., “Clinical and Experimental Effects of Growth Hormone Secretagogues on Various Organ Systems”,Horm Res51 (suppl 3), pp. 16-20 (1999).
Crissey Todd M.
Pfizer Inc.
Weddington Kevin E.
Wichtowski John A.
LandOfFree
Compositions and methods for stimulating gastrointestinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for stimulating gastrointestinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for stimulating gastrointestinal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3483039